- VEGFR2 Inhibitors
- Accession Number
- Not Available
Drug Drug Description Ramucirumab An antineoplastic agent and direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis and enhance tumor blood supply.
- Drugs & Drug Targets
Drug Target Type Ramucirumab Vascular endothelial growth factor receptor 2 target